文献速递类风湿关节炎

类风湿关节炎中的SUMO组分

The SUMO components in rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

综述总结SUMO化与去SUMO化由SUMO组分调控并维持动态平衡,组分失调可改变靶蛋白功能并参与类风湿关节炎(RA)发病。文中汇总SUMO-1、SUMO-2/3、SAE1/Uba2、Ubc9、PIASs和SENPs在RA发病机制中的作用及作为治疗靶点的潜在价值,并指出SUMO组分单核苷酸多态性(SNP)与疾病易感性相关,目前RA中仅报道SUMO-4的SNP位点。

要点

  • SUMO组分通过SUMO化与去SUMO化维持动态平衡,失调可改变靶蛋白功能并参与RA发病。
  • SUMO-1、SUMO-2/3、SAE1/Uba2、Ubc9、PIASs和SENPs被报道参与RA发病,并被视为潜在治疗靶点。
  • SUMO组分SNP与疾病易感性相关,RA中目前仅报道SUMO-4的SNP位点。

核心结论

  • SUMO组分失调打破SUMO化与去SUMO化的动态平衡,改变靶蛋白功能,参与RA发病。
  • 多种SUMO组分被报道参与RA发病,其作为治疗靶点的潜在价值受到关注。
  • SUMO组分SNP与疾病易感性相关,RA中目前仅报道SUMO-4的SNP位点。

研究设计与样本

  • 本文为系统综述,系统概述SUMO组分的总体特征并总结其对RA的影响。

主要发现

  • SUMO蛋白可共价或非共价、可逆地连接到多种底物的赖氨酸残基上,该过程称为SUMO化,反向过程称为去SUMO化。
  • 生理状态下SUMO化与去SUMO化由SUMO组分调控并维持动态平衡。
  • SUMO-1、SUMO-2/3、SAE1/Uba2、Ubc9、PIASs和SENPs被报道参与RA发病。
  • SUMO组分SNP被报道与疾病易感性相关,RA中目前仅报道SUMO-4的SNP位点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Small ubiquitin-like modifier (SUMO) proteins can reversibly attach covalently or non-covalently to lysine residues of various substrates. The processes are named SUMOylation and de-SUMOylation, which maintain a dynamic balance in the physiological state, and are regulated by SUMO components. However, the dysregulation of components disturbs the balance and alters the functions of target proteins, which causes the occurrence of diseases. To date, certain SUMO components, including SUMO-1, SUMO-2/3, SAE1/Uba2, Ubc9, PIASs (protein inhibitors of activated signal transducer and activator of transcription) and SENPs (SUMO-specific proteases), have been found to participate in the pathogenesis of RA and their potential value as therapeutic targets also have been highlighted. In addition, single nucleotide polymorphisms (SNPs) in the SUMO components have been reported to be associated with disease susceptibility. Until now, only the SNP site of SUMO-4 has been reported in RA. Here we provided a systematic overview of the general characteristics of SUMO components and highlighted a summary of their impact on RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wu Q, Jiang Y, You C, et al. The SUMO components in rheumatoid arthritis. Rheumatology (Oxford). 2022. PMID: 35595244. doi:10.1093/rheumatology/keac297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。